Pro Medicus Limited (ASX:PME)
Australia · Delayed Price · Currency is AUD 176.42
-2.97 (-1.66%)
Sep 1, 2026, 4:10 PM AEST
Pro Medicus Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | 265.34 | 115.22 | 82.79 | 60.65 | 44.44 |
Depreciation & Amortization | 1.14 | 0.99 | 0.85 | 0.83 | 0.81 |
Other Amortization | 6.93 | 6.24 | 7.66 | 7.09 | 6.5 |
Loss (Gain) From Sale of Investments | -174.24 | 0.1 | 0.54 | 0.21 | 1.07 |
Stock-Based Compensation | 4.18 | 2.88 | 1.93 | 1.23 | 0.03 |
Other Operating Activities | -9.59 | -7.91 | -3.67 | -3.41 | -3.97 |
Change in Accounts Receivable | -33.56 | -16.18 | -8.17 | -13.48 | -3.59 |
Change in Inventory | - | - | 0.01 | 0.02 | -0.04 |
Change in Accounts Payable | 1.61 | 2.96 | 3.4 | 1.5 | 1.58 |
Change in Unearned Revenue | 16.8 | 5.64 | 6.88 | 7.27 | 2.86 |
Change in Income Taxes | 3.28 | 1.7 | -4.14 | 0.24 | 4.6 |
Change in Other Net Operating Assets | -5.5 | -0.48 | -1.3 | 0.27 | 0.35 |
Operating Cash Flow | 127.48 | 111.33 | 81.98 | 62.54 | 61.58 |
Operating Cash Flow Growth | 14.51% | 35.81% | 31.09% | 1.56% | 58.54% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Capital Expenditures | -0.44 | -0.44 | -0.31 | -0.3 | -0.24 |
Sale (Purchase) of Intangibles | -8.24 | -6.94 | -6.39 | -6.15 | -8.79 |
Investment in Securities | -12.59 | -6.74 | -71.38 | -3.35 | -8.53 |
Other Investing Activities | 9.04 | 7.54 | 4.8 | 2.24 | 0.65 |
Investing Cash Flow | -12.24 | -6.58 | -73.28 | -7.56 | -16.91 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Long-Term Debt Repaid | -0.63 | -0.65 | -0.52 | -0.57 | -0.51 |
Net Debt Issued (Repaid) | -0.63 | -0.65 | -0.52 | -0.57 | -0.51 |
Repurchase of Common Stock | -10.14 | -7.85 | -2.77 | -0.85 | -4.02 |
Common Dividends Paid | -64.78 | -49.11 | -36.55 | -26.11 | -18.79 |
Financing Cash Flow | -75.55 | -57.62 | -39.84 | -27.53 | -23.31 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | -0.7 | 0.29 | -0.05 | 0.14 | 0.26 |
Net Cash Flow | 39 | 47.43 | -31.19 | 27.59 | 21.62 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 127.04 | 110.89 | 81.67 | 62.24 | 61.34 |
Free Cash Flow Growth | 14.56% | 35.78% | 31.23% | 1.46% | 58.45% |
Free Cash Flow Margin | 48.55% | 52.07% | 50.57% | 49.83% | 65.63% |
Free Cash Flow Per Share | 1.21 | 1.06 | 0.78 | 0.59 | 0.59 |
Levered Free Cash Flow | 98.87 | 91.47 | 68.87 | 46.18 | 42.34 |
Unlevered Free Cash Flow | 98.87 | 91.47 | 68.87 | 46.18 | 42.34 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.11 | 0.11 | 0.08 | 0.08 | 0.1 |
Cash Income Tax Paid | 57.79 | 46.22 | 38.85 | 23.46 | 7.18 |
Change in Working Capital | 33.41 | -13.13 | -8.45 | -5.8 | 9.42 |